A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects

NCT05948774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MT200605 for Injection
DRUG: MT200605 Placebo

Sponsor

Shaanxi Micot Pharmaceutical Technology Co., Ltd.